Lynparza 150 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB26FX3ZK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,135
Award facts
- Contract value 100% obligated
- $21,135.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $21,135.22 for LYNPARZA 150 MG tablets (120 count) on October 28, 2025, with a completion date of November 19, 2025. This firm fixed-price contract, awarded without a set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same location serving as the place of performance for this order—is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support Department of Defense healthcare programs globally. LYNPARZA is a specialized oncology medication, consistent with the company's portfolio of therapeutic products serving the Defense Health Agency and other federal healthcare systems. The contract underscores AmerisourceBergen's role as a key provider within the DLA's medical supply chain and its demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB26FX3ZK?
SPE2DB26FX3ZK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FX3ZK worth?
The government has obligated $21,135 on SPE2DB26FX3ZK.
Is contract SPE2DB26FX3ZK an order under another contract?
Yes. SPE2DB26FX3ZK is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3ZK competed?
The extent of competition for SPE2DB26FX3ZK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award